Baseimmune is a biotech startup founded to create the next generation of vaccines.
Baseimmune has raised $11.4M in total funding. The most recent round was Series A. The last funding was announced in February 2024.
Baseimmune's investors include Maki.vc, Cherry Ventures, IQ Capital, Hoxton Ventures, Creator Fund.
Baseimmune is headquartered in London, United Kingdom.
Baseimmune is a biotech startup founded to create the next generation of vaccines.
Baseimmune is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Baseimmune — Funding & Investors." VCBacked, February 26, 2024, https://www.vcbacked.co/company/baseimmune. Accessed September 15, 2026.
VCBacked. (2024). Baseimmune — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/baseimmune
{{cite web |title=Baseimmune — Funding & Investors |url=https://www.vcbacked.co/company/baseimmune |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated